A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery.

Servando Hernandez Vargas,Christie Lin,Solmaz AghaAmiri,Julie Voss,Naruhiko Ikoma,Hop S Tran Cao,Sukhen C Ghosh,Adam J Uselmann,Ali Azhdarinia

Proceedings of SPIE--the International Society for Optical Engineering（2020）

引用 3|浏览10

暂无评分

摘要

Our findings demonstrate that the use of clinically relevant fluorescence imaging instrumentation enhances the evaluation of promising FGS agents for visualization of residual disease.

查看译文

关键词

Cancer surgery,fluorescence system instrumentation,fluorescence-guided surgery,intraoperative imaging,residual disease,somatostatin receptor,targeted agent

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要